High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells
- 14 December 1995
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 60 (2-3) , 149-157
- https://doi.org/10.1016/0167-0115(95)00124-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Gene Expression of VIP Receptor in Rat LymphocytesBiochemical and Biophysical Research Communications, 1994
- Human Vasoactive Intestinal Peptide1 Receptors Expressed by Stable Transfectants Couple to 2 Distinct Signaling PathwaysBiochemical and Biophysical Research Communications, 1994
- Small-cell lung carcinoma: Inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibodyLife Sciences, 1993
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Type I receptors for PACAP (a neuropeptide even more important than VIP?)Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP)FEBS Letters, 1993
- Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophagesFEBS Letters, 1993
- Molecular anatomy of the neuro-immune connectionInternational Journal of Neuroscience, 1991
- Immunolocalization of tyrosine hydroxylase and vasoactive intestinal polypeptide in nerve fibers innervating human palatine tonsil and paratonsillar glandsNeuroscience Letters, 1990
- Detection of vasoactive intestinal peptide and localization of its mRNA within granulomas of murine schistosomiasisCellular Immunology, 1990